Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: Results of a 17 year study

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 11, 2013, Pages 6905-6911

  Afsharfard, Aboulfazl ^a   Mozaffar, Mohammad ^a   Orang, Elahe ^b   Tahmasbpour, Eisa ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Breast cancer; Epidemiology; Iran; Staging; Trends; Tumor type

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; IRAN; LUNG CARCINOMA; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; TIME; TUMOR INVASION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84892456953     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.11.6905     Document Type: Article

References (29)

1. Agarwal G, Pradeep PV, Aggarwal V, et al (2007). Spectrum of breast cancer in Asian women. World J Surg, 31, 1031-40.
2. Benz CC (2008). Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol, 66, 65-74.
3. Botteri E, Bagnardi V, Goldhirsch A, et al (2010). Axillary lymph node involvement in women with breast cancer: does it depend on age. Clin Breast Cancer, 10, 318-21.
4. Colleoni M, Rotmensz N, Robertson C, et al (2002). Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol, 13, 273-9.
5. Fisher CJ, Egan MK, Smith P, et al (1997). Histopathology of breast cancer in relation to age. Br J Cancer, 75, 593-6.
6. Fleming ID, Cooper JS, Henson DE, et al (1997). American Joint Committee on Cancer: AJCC Cancer Staging Manual, 5th edition. Philadelphia, PA: Lippincott- Raven.
7. Foxcroft LM, Evans EB, Porter AJ (2004). The diagnosis of breast cancer in women younger than 40. Breast, 13, 2-306.
8. Gennari R, Curigliano G, Rotmensz N, et al (2004). Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer, 101, 1302-10.
9. Harirchi I, Ebrahimi M, Zamani N, et al (2000). Breast cancer in Iran: a review of 903 case records. Public Health, 114, 143-5.
10. Harirchi I, Karbakhsh M, KashefiA, et al (2004). Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev, 5, 24-7.
11. Harirchi I, Karbakhsh M, Montazeri A, et al (2010). Decreasing trend of tumor size and downstaging in breast cancer in Iran: results of a 15-year study. Eur J Cancer Prev, 19, 126-30.
12. Harirchi I, Kolahdoozan S, Karbakhsh M, et al (2011). Twenty years of breast cancer in Iran: downstaging without a formal screening program. Ann Oncol, 22, 93-7.
13. Karihtala P, Winqvist R, Bloigu R, et al (2010). Long-term observational follow-up study of breast cancer diagnosed in women =40 years old. Breast, 19, 456-61.
14. Medical Advisory Secretariat (2007). Screening Mammography for women aged 40 to 49 Years at average risk for breast cancer: an evidence-based analysis. Ontario Health Technology Assessment Series, 7, 1-29.
15. Mohammad K, Sadat Hashemi SM, Farahani FK (2004). Age at natural menopause in Iran. Maturitas, 49, 321-6.
16. Molino A, Giovannini M, Auriemma A, et al (2006). Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol, 59, 226-33.
17. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91.
18. Mousavi SM, Harirchi I, Ebrahimi M, et al (2008). Screening for breast cancer in Iran: a challenge for health policy makers. Breast J, 14, 605-6.
19. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
20. Orang E, Tahmasbpour E, Afsharfard A (2013). Predictive role of tumor size in breast cancer with axillary lymph node involvement - can size of primary tumor be used to omit an unnecessary axillary lymph node dissection. Asian Pac J Cancer Prev, 14, 717-22.
21. Parkin DM, Bray F, Ferley J, et al (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6.
22. Parkin DM, Fernandez LM (2006). Use of statistics to assess the global burden of breast cancer. Breast J, 12, 70-80.
23. Porter PL (2009). Global trends in breast cancer incidence and mortality. Salud Publica Mex, 51, 141-6.
24. Sharma K, Costas A, Shulman LN, et al (2012). A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol, 121873.
25. Shibuya K, Mathers CD, Boschi-Pinto C, et al (2002). Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer, 2, 37.
26. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30.
27. Smigal C, Jemal A, Ward E, et al (2006). Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin, 56, 168-83.
28. Winchester DP, Osteen RT, Menck HR (1996). The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer, 78, 1838-43.
29. Yancik R, Wesley MN, Ries LA, et al (2001). Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA, 285, 885-92.